Citation 129888

SCHWARTNER,C: BORS,W: MICHEL,C: FRANCK,U: MULLER-JAKIC,B: NENNINGER,A: ASAKAWA,Y: WAGNER,H:. (1995). EFFECT OF MARCHANTINS AND RELATED COMPOUNDS ON 5-LIPOXYGENASE AND CYCOOXYGENASE AND THEIR ANTIOXIDANT PROPERTIES: A STRUCTURE ACTIVITY RELATIONSHIP STUDY.. 2(2)

Citation Details

Title	EFFECT OF MARCHANTINS AND RELATED COMPOUNDS ON 5-LIPOXYGENASE AND CYCOOXYGENASE AND THEIR ANTIOXIDANT PROPERTIES: A STRUCTURE ACTIVITY RELATIONSHIP STUDY.
Authors	SCHWARTNER,C: BORS,W: MICHEL,C: FRANCK,U: MULLER-JAKIC,B: NENNINGER,A: ASAKAWA,Y: WAGNER,H:
Year	1995
Volume	2
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
2	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN A	ACTIVE
2	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN A	ACTIVE
3	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN A	ACTIVE
4	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN B	ACTIVE
5	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN B	ACTIVE
6	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN B	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MARCHANTIN B	ACTIVE
8	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN D	ACTIVE
9	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN D	ACTIVE
10	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN E	ACTIVE
11	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN E	ACTIVE
12	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MARCHANTIN E	ACTIVE
13	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALEATIN B	ACTIVE
14	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALEATIN B	ACTIVE
15	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PALEATIN B	ACTIVE
16	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RICCARDIN C,ISO:	ACTIVE
17	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RICCARDIN C,ISO:	ACTIVE
18	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RICCARDIN C,ISO:	ACTIVE
19	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RICCARDIN C	ACTIVE
20	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RICCARDIN C	ACTIVE
21	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERROTTETIN D	ACTIVE
22	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERROTTETIN D	ACTIVE
23	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PERROTTETIN D	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PERROTTETIN D	ACTIVE
25	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RADULANIN H	ACTIVE
26	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RADULANIN H	ACTIVE
27	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RADULANIN H	ACTIVE

Citation 129888

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1